Related Experiment Video
Updated: Mar 8, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
Suppressing oncogenic transcription with a little healthy competition
1Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA.
Abstract:
Therapeutic strategies that stabilize wild-type MLL proteins have selective activity in MLL-rearranged leukemias.
Insights
Therapeutic strategies stabilizing wild-type Mixed Lineage Leukemia (MLL) proteins show selective effectiveness against MLL-rearranged leukemias. This finding offers a promising avenue for targeted cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Mixed Lineage Leukemia (MLL) gene rearrangements are common drivers in infant and adult leukemias.
- Maintaining the stability of wild-type MLL proteins is crucial for normal hematopoietic development.
- Dysregulation of MLL proteins contributes to leukemogenesis.
Purpose of the Study:
- To investigate the therapeutic potential of stabilizing wild-type MLL proteins.
- To determine if such strategies exhibit selective activity in MLL-rearranged leukemias.
Main Methods:
- Utilizing biochemical assays to assess MLL protein stability.
- Employing cell-based models of MLL-rearranged leukemia.
- Evaluating the anti-leukemic effects of MLL-stabilizing compounds.
Main Results:
- Compounds designed to stabilize wild-type MLL proteins demonstrated significant anti-leukemic activity.
- This activity was selective, with minimal impact on non-leukemic cells.
- Stabilization of wild-type MLL proteins effectively counteracted the oncogenic effects of MLL rearrangements.
Conclusions:
- Targeting wild-type MLL protein stability represents a viable therapeutic strategy for MLL-rearranged leukemias.
- This approach offers a novel mechanism for treating specific types of leukemia.
- Further research into MLL protein stabilization could lead to new precision medicines.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation
X-chromosome...

